Health & Fitness
Health and Fitness
Health and Fitness 
Wed, July 13, 2011
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - WOPRAI
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
[ Wed, Jul 13th 2011
] - Market Wire
Tue, July 12, 2011
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
[ Tue, Jul 12th 2011
] - Market Wire
Snel wereldwijd succes voor iPhone MelApp gemeld door Health Discovery Corporation
SAVANNAH, Ga.--([ BUSINESS WIRE ])--Health Discovery Corporation (OTCBB: HDVY), een in moleculaire diagnostiek gespecialiseerd bedrijf dat gepatenteerde en geavanceerde wiskundige technieken gebruikt voor gepersonaliseerde geneesmiddelen, zegt dat de grensverleggende iPhone app MelApp de potentie heeft om de vroege opsporing van melanoom, de wereldwijd snelst groeiende vorm van kanker, ingrijpend te veranderen. Binnen enkele dagen na de publicatie wordt MelApp gebruikt door consumenten in 24 landen, waaronder Nederland. Bovendien is MelApp in die paar dagen doorgedrongen tot de top 100 van hoogst scorende apps in twintig landen in de categorie Gezondheidszorg en Fitness.
Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal welke als enige juridische geldigheid beoogt.